Peptide News Digest
Evidence Brief 10 min read

Thanksgiving on Ozempic, Wegovy, Mounjaro or Zepbound: Big Meals, Alcohol, Nausea and When to Get Help

What the Wegovy, Ozempic, Zepbound, Mounjaro and Foundayo labels say about nausea, missed doses and warning signs, and dietitians' advice on plates and drinks.

Key points

  • Thanksgiving is Thursday, November 26, 2026. All five drugs covered here (Wegovy, Ozempic, Zepbound, Mounjaro and Foundayo) carry label language that they delay gastric emptying, which is why a heavy meal can sit longer.
  • In placebo-controlled weight-loss trials, gastrointestinal side effects were reported by 73% on the Wegovy injection versus 47% on placebo, 56% on each Zepbound dose versus 30%, and 60% to 69% on Foundayo versus 37%. The labels say most of these reactions occurred while the dose was being increased.
  • The Wegovy pill must be taken on an empty stomach with up to 4 ounces of water, with a wait of at least 30 minutes before food, drinks or other pills. Foundayo and the weekly injections can be taken with or without food.
  • UC Davis Health's holiday guide says not to skip a GLP-1 dose to eat more. Missed-dose rules in the labels differ by drug and are for accidental misses. Any planned change should come from the prescriber.
  • None of the U.S. labels addresses alcohol. A 2025 joint nutrition advisory says alcohol may worsen nausea and reflux and should be minimized, and NIDDK warns that drinking without enough food can cause low blood glucose in people on insulin or similar drugs.
  • Severe abdominal pain that will not go away (possible pancreatitis), upper abdominal pain with fever or yellowing (possible gallbladder disease), and vomiting or diarrhea that will not stop (dehydration and kidney injury risk) are label warning signs that call for medical help.

A holiday built around one big meal, on drugs that slow the stomach

Thanksgiving falls on Thursday, November 26, this year. For people taking semaglutide (Ozempic, the Wegovy injection or the Wegovy pill), tirzepatide (Mounjaro or Zepbound) or Lilly's orforglipron pill (Foundayo), the day stacks a large, rich meal on top of a drug whose label says it delays gastric emptying. Food leaves the stomach more slowly, and a heavy plate stays there longer.

UC Davis Health's holiday guide, published October 20, 2026 and medically reviewed by senior registered dietitian Angela Salas, describes it in plain terms: heavier, higher-fat holiday foods "stay in your stomach longer, which can cause you to experience cramps, bloating and nausea."

This article sticks to what the current U.S. prescribing information, a 2025 joint nutrition advisory and named clinicians say about a big meal, drinks and the symptoms that need medical attention. It does not tell anyone to change a dose. That decision belongs to the prescriber. For nausea on an ordinary week, see our guide to how long GLP-1 nausea lasts and what helps.

How often trial participants had nausea, vomiting or diarrhea

The labels report stomach and bowel side effects from placebo-controlled trials. The numbers below are the share of participants who reported each problem at any point during the trial. The Wegovy and Zepbound weight-loss trials lasted 64 to 72 weeks.

  • Wegovy injection (2.4 mg weekly): In three double-blind trials with 2,116 adults treated for up to 68 weeks, 73% reported gastrointestinal adverse reactions versus 47% on placebo. Nausea was reported by 44% versus 16%, and diarrhea by 30% versus 16%. Severe gastrointestinal reactions occurred in 4.1% versus 0.9%.
  • Wegovy tablets (25 mg daily): In one trial of 204 adults treated for up to 64 weeks, severe gastrointestinal reactions occurred in 2% versus 0% on placebo, and the label says the common side effects were similar in type and frequency to the injection's.
  • Zepbound: In two trials with 2,519 treated adults followed for up to 72 weeks, 56% at each dose (5, 10 and 15 mg) reported gastrointestinal reactions versus 30% on placebo. Nausea ran 25% to 29% versus 8%.
  • Foundayo: In two weight-management trials, gastrointestinal reactions were reported by 60% to 69% across the three daily doses versus 37% on placebo, and nausea by 26% to 35% versus 10%.
  • Ozempic and Mounjaro: These labels draw on type 2 diabetes trials at diabetes doses. Nausea was reported by 15.8% on Ozempic 0.5 mg and 20.3% on 1 mg versus 6.1% on placebo, and by 12% to 18% on Mounjaro 5 to 15 mg versus 4%.

Each label also says rates from one drug's trials cannot be directly compared with another drug's, so the list above does not rank them.

Timing matters more for a single holiday. The Wegovy label says these reactions were most often reported during dose escalation, the step-by-step climb to the full dose, and the Zepbound label says most nausea, vomiting and diarrhea events happened during escalation and decreased over time. Someone whose next step-up lands on Thanksgiving week is in the period when the trials recorded most of these complaints. Whether to move that step is a question for the prescriber, and our dosing schedules guide explains how the climb works for each drug.

Thursday morning on the Wegovy pill or Foundayo

The Wegovy tablet comes with the strictest routine of these drugs. Its label says to take one tablet in the morning on an empty stomach with up to 4 ounces of water, and no other liquid. After that, wait at least 30 minutes before eating, drinking anything else or taking other pills. On a holiday morning that means the first coffee, the taste of the gravy and any other medicines all wait for the half hour.

Foundayo has no such rule. Its label says to take it once daily with or without food.

The weekly injections (Ozempic, Wegovy, Mounjaro and Zepbound) can also be taken with or without food, according to their labels. UC Davis Health's guide adds one food suggestion for injection users: eat lower-fat foods on the day of the injection, and possibly the day after if side effects are bothering you.

Do not plan a skipped dose around the turkey

UC Davis Health's guide answers the question directly: "No, you should not skip your GLP-1 dose during the holidays." It says skipping a dose and then overeating can bring blood sugar spikes, indigestion and discomfort. Any change to the schedule should come from the person who prescribes the drug.

The labels do spell out what to do when a dose is missed by accident, and the rules differ by drug:

  • Wegovy injection: If the next dose is more than 2 days away, take the missed one as soon as possible. If it is less than 2 days away, skip it and resume on the usual day. After 2 or more missed weeks in a row, the label says to restart the dose climb at a lower dose.
  • Wegovy tablets: Skip the missed tablet and take the next one the following day.
  • Ozempic: Take it within 5 days of the missed dose. After 5 days, skip it and resume on the usual day.
  • Zepbound and Mounjaro: Take it within 4 days (96 hours). After 4 days, skip it. The labels also say not to take two doses within 3 days of each other.
  • Foundayo: Take it as soon as possible, and do not double the next dose. After 7 or more missed doses in a row, the label says to restart the climb at a lower dose.

The labels give one reason for the restart rules: a lower restart dose reduces the risk of gastrointestinal side effects. A long gap can mean climbing the dose ladder again.

Smaller portions, and don't fast all day

The most detailed eating guidance comes from a joint advisory by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society, published in the American Journal of Clinical Nutrition in 2025. It says nausea "often occurs in the morning or after longer periods without eating" and that "vomiting is more likely to occur with large meals." For diarrhea, it says avoiding large or high-fat meals can help. Its table of eating habits puts regular small meals, flexibility with food choices and "portion-controlled treats" on the side to encourage, and long stretches without food and large meals on the side to minimize.

That cuts against a common Thanksgiving habit. Lindsay Malone, a registered dietitian at Case Western Reserve University, told the Associated Press, in a story carried by FOX television stations on November 9: "Many people will try to fast the whole day and they arrive either starving or their blood sugar is low." She suggested filling about half the plate with vegetables such as green beans, Brussels sprouts or salad.

UC Davis Health's guide gets specific about the table itself. Take small portions and a few bites of several dishes. Eat slowly, wait before a second serving and stop once you feel satisfied. It lists gravy, stuffing, mac and cheese, candied yams, pies, cookies and cocktails as foods to limit, and suggests skinless light-meat turkey, winter squash, lentils and roasted vegetables. If you suddenly feel uncomfortably full, the guide says to stop eating, take only sips of water, and stand or take a short walk. It tells readers to contact a doctor if that full feeling persists or becomes severe.

These are clinicians' recommendations. None of the sources above cites a trial that tested eating strategies for a single holiday-size meal on these drugs.

Two related problems show up over weeks rather than in one afternoon. Some people find the pull of the dessert table much weaker on these drugs, which our food noise article covers, and some end up eating too little day to day, covered in our piece on calorie, fiber, vitamin D and iron gaps. People who have stepped down or stopped their dose face a different holiday table. The maintenance playbook covers what the SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN trials found.

The labels say nothing about alcohol

We searched the current U.S. prescribing information and patient guides for Wegovy, Ozempic, Zepbound, Mounjaro and Foundayo. None of them gives guidance on drinking. The word turns up only in injection instructions, ingredient lists and disease names.

Other sources fill some of the gap. The 2025 nutrition advisory says alcohol "may also worsen nausea and gastroesophageal reflux with GLP-1 therapy and should be minimized," and lists minimal alcohol intake among habits to encourage. UC Davis Health's guide says people on these drugs often report not wanting to drink, and that those who do drink say it affects them differently. Its advice for anyone who does drink: go slowly, choose lower-sugar drinks, and have a glass of water before and after. Research on whether these drugs reduce drinking is covered in our article on GLP-1 drugs and alcohol.

For people with diabetes who take insulin or other glucose-lowering medicines, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) adds a specific warning. Drinking too much alcohol without enough food can cause low blood glucose, "especially if you haven't eaten in a while," and alcohol can keep you from feeling the first symptoms. NIDDK says it is safer to eat some food when you drink. A guest who skipped breakfast and lunch and starts on wine before dinner fits that description.

If you also take insulin or a sulfonylurea

All five labels warn that the risk of hypoglycemia (low blood sugar), including severe hypoglycemia, rises when these drugs are combined with insulin or a sulfonylurea, a type of diabetes pill that makes the body release more insulin. The gap can be large. In Zepbound's Study 2, which enrolled adults with type 2 diabetes, blood glucose under 54 mg/dL was reported in 10.3% of those also taking a sulfonylurea and 2.1% of those who were not. Foundayo's Trial 2 found 7% versus 0.5%. In a Mounjaro trial lasting up to 104 weeks in people on a sulfonylurea, 9.9% to 13.8% had glucose under 54 mg/dL, depending on dose, and on Ozempic plus a sulfonylurea, severe hypoglycemia occurred in 0.8% at 0.5 mg and 1.2% at 1 mg.

Thanksgiving can stack several of NIDDK's listed causes of low blood glucose into one day: not eating enough carbohydrate, drinking without enough food, and being sick and unable to keep food down. The Wegovy patient guide lists the warning signs: dizziness or lightheadedness, sweating, shakiness, confusion or drowsiness, headache, blurred vision, slurred speech, fast heartbeat, anxiety, irritability or mood changes, hunger, weakness and feeling jittery.

NIDDK's instructions for a low reading (below your target or under 70 mg/dL) are to take 15 to 20 grams of glucose or carbohydrate right away, such as four glucose tablets or half a cup of regular fruit juice. Check again after 15 minutes and repeat until the level is back in range. If glucose drops so low that a person cannot treat it themselves, NIDDK says glucagon is the best treatment, and that family or friends should call 911 right away after giving it, or if no glucagon kit is on hand.

Whether to lower an insulin or sulfonylurea dose for a day of unusual eating is a question to ask the prescriber before Thursday. The labels say prescribers may need to reduce those doses, and NIDDK tells patients to work with their health care team on adjustments.

Symptoms that need a call to a doctor

UC Davis Health treats an uncomfortably full stomach as something to manage at the table, with a call to the doctor if it persists or gets severe. A few patterns call for help sooner, and the labels name them.

Severe stomach pain that will not go away. Every label warns about acute pancreatitis, inflammation of the pancreas. The patient guides say to stop the drug and call a health care provider right away for severe pain in the abdomen that does not go away, with or without nausea or vomiting, sometimes felt from the abdomen through to the back. It is uncommon: in Wegovy's weight-loss trials, adjudicated pancreatitis occurred at 0.2 cases per 100 patient-years versus less than 0.1 on placebo, and in Zepbound's two weight-loss trials, 0.2% of each group had it.

Pain in the upper abdomen with fever, yellow skin or eyes, or clay-colored stools. Those are the gallbladder warning signs the Wegovy patient guide lists, with an instruction to call a provider. Gallstones were reported in 1.6% of adults on the Wegovy injection versus 0.7% on placebo, and in 2.5% on Wegovy tablets versus 1%. Zepbound's label reports gallbladder inflammation (cholecystitis) in 0.7% versus 0.2%.

Vomiting or diarrhea that does not stop, or not being able to keep fluids down. The labels warn of acute kidney injury from dehydration and describe postmarketing reports, some requiring dialysis. Most of those reports involved people whose nausea, vomiting or diarrhea had left them dehydrated. In the trials, acute kidney injury was rare: 0.4 cases per 100 patient-years on Wegovy versus 0.2 on placebo, and 0.5% on Zepbound versus 0.2%. The patient guides tell people to drink fluids and to tell their provider right away about nausea, vomiting or diarrhea that does not go away. MedlinePlus lists early signs of dehydration as thirst, dry mouth, urinating little, darker urine, headache and muscle cramps. Very dark or no urine, dizziness, a racing heart and confusion are signs of severe dehydration. MedlinePlus says to call 911 if the person passes out or has a change in alertness, such as confusion or a seizure.

Signs of low blood sugar in someone on insulin or a sulfonylurea, as described in the section above, especially if they do not improve after treatment.

The patient guides also tell people to get medical help right away for signs of a serious allergic reaction, such as swelling of the face, lips, tongue or throat or trouble breathing.

A procedure scheduled for the following week

The same slow stomach emptying is behind a separate warning on every label. There have been rare reports of pulmonary aspiration, stomach contents entering the lungs, in people on these drugs who had general anesthesia or deep sedation, even when they reported following fasting instructions. The labels say the data are not enough to recommend a specific fix and tell patients to inform their care team before any planned procedure. If a colonoscopy, endoscopy or surgery is booked for the days after Thanksgiving, call the team ahead of time. Our surgery and anesthesia guide covers how anesthesia societies have handled it.

For the person doing the cooking

A guest who takes a small plate, passes on seconds or leaves half a slice of pie may be following the advice above. Authors of the 2025 advisory wrote that in their clinical practice "a substantial number of individuals are less interested in food" on these drugs. Urging another helping works against that.

Roasted vegetables, plain light-meat turkey and water on the table all fit what UC Davis Health suggests.

Updates and corrections

No corrections yet.

Limitations

  • Side effect rates come from long placebo-controlled trials and describe the share of participants who reported a problem at any point. They do not measure what happens after one large meal, and the labels say rates cannot be compared across different drugs' trials.
  • Ozempic and Mounjaro rates come from type 2 diabetes trials at diabetes doses and are not directly comparable with the weight-loss trials of Wegovy, Zepbound and Foundayo.
  • The eating and alcohol advice comes from a clinical advisory, a health system's dietitian-reviewed guide and a dietitian quoted by the Associated Press. None of these sources cites a trial that tested strategies for a holiday-size meal on these drugs.
  • Hypoglycemia treatment steps come from NIDDK guidance for people with diabetes in general and are not specific to GLP-1 drugs. People on insulin or sulfonylureas should follow the plan their own care team gives them.
  • This article does not cover compounded semaglutide or tirzepatide, Rybelsus, or drugs bought outside the regulated supply, which may differ in dose and labeling.

Citations

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
    Low Blood Glucose (Hypoglycemia)
    patient-education National Institute of Diabetes and Digestive and Kidney Diseases 2021
  10. 10.
    Dehydration (MedlinePlus Medical Encyclopedia)
    patient-education MedlinePlus 2025

Peptides in this article

Full peptide profiles with evidence levels, dosing data, and safety notes live on peptidelist.org.

Related insights